Clinical Trials Logo

Anemia clinical trials

View clinical trials related to Anemia.

Filter by:

NCT ID: NCT04246021 Completed - Cancer Clinical Trials

Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy

Start date: June 15, 2016
Phase: N/A
Study type: Interventional

This study is a nonrandomized, single arm, open-label study stratified by iron-deficiency status.

NCT ID: NCT04233944 Terminated - Anemia Clinical Trials

Uganda Birth Cohort Study

UBC
Start date: November 15, 2014
Phase:
Study type: Observational

The UBC was a USAID-funded longitudinal prospective cohort study of pregnant women (n= 5030) aged 15-49 years from rural North and South-Western regions of Uganda, conducted between 2014 and 2016. The aim of the UBC study was to observationally follow pregnant women and their newborns until 2 years of age and compare changes over time in communities that were part of an ongoing USAID project called the Community Connector (CC) compared to those communities that were not included in the Community Connector project.

NCT ID: NCT04231292 Recruiting - Clinical trials for Patient of Anemia in Chronic Renal Failure With Hemodialysis

A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis

Start date: March 1, 2020
Phase: Phase 2
Study type: Interventional

A multicenter randomized, single blind, active comparator controlled phase 2 study which is to evaluate the effectiveness, safety and the PK/PD characteristics of different doses, frequencies and routes of pegerythropoietin Injection (RD01) as maintenance therapy in the treatment of anemia in chronic renal failure patients with hemodialysis

NCT ID: NCT04228627 Active, not recruiting - Pregnancy Related Clinical Trials

Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial

FAIR
Start date: August 1, 2020
Phase: Phase 4
Study type: Interventional

Prevalence of anemia in Asia is more than 50%. All woman who book for antenatal care with non-anaemic iron deficiency (NAID) can be offered therapeutic doses of parentral iron, as a directly observed complete therapy, to prevent of maternal anaemia and fetal growth restriction. The investigators will compare this intervention with usual care in a multicentre randomised trial.

NCT ID: NCT04216030 Completed - Clinical trials for Iron Deficiency Anemia

IP Peru, Bioavailability of Iron From Potatoes

IPPERU
Start date: May 14, 2019
Phase: N/A
Study type: Interventional

To combat iron deficiency in Low and Middle-Income Countries, sustainable food-based solutions have to be implemented to serve populations, not only individuals. One solution is the introduction of iron biofortified staple crops on market level. Before market level introduction, the bioavailability of iron in the new biofortified Irish Potato (IP) breed needs to be assessed. In this study the investigator compares the fractional and total iron absorption after extrinsic stable isotope labelling of the new biofortified high iron IP variety and a normal market level IP variety. The study is conducted in Peruvian women of reproductive age with marginal iron status.

NCT ID: NCT04212819 Completed - Anemia Clinical Trials

Before and After Erythrocyte Suspension Transfusion

Start date: January 1, 2014
Phase: N/A
Study type: Interventional

Hypoperfusion, hypoxia and ischemia occurs in circulation as a result of anemia. All of these situations lead to oxidative stress and endothelial dysfunction in the organism. In this study, the investigators aimed to investigate the oxidant-antioxidant balance and asymmetric dimethylarginine (ADMA) levels in patients that have symptomatic anemia in need of erythrocyte suspension (ES) transfusion. To the best of the investigators knowledge, there have been few studies in the literature on anemia and total oxidant, total antioxidant and ADMA levels. We aimed to observe changes in oxidative - antioxidant ADMA levels before and after ES transfusion.

NCT ID: NCT04208451 Terminated - Anemia Clinical Trials

The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

In this study are included patients on hemodialysis with anemia (levels of Hemoglobin<110). After baseline measurements tha patients take Standardized Aronia melanocarpa extract for one mont and then all measurements were repeated.

NCT ID: NCT04205266 Recruiting - Clinical trials for Anemia, Iron Deficiency

IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding

Start date: February 14, 2020
Phase: Phase 4
Study type: Interventional

This study investigates whether intravenous (IV) iron [Feraheme (ferumoxytol) injection)] is a better treatment than oral iron pills (ferrous sulfate) for correcting anemia in women who have heavy menstrual bleeding and anemia. Investigators will study whether women's blood counts respond better, respond more quickly, and if women prefer the IV treatment or the oral treatment. Women who have heavy menstrual bleeding and anemia will be randomly assigned to receive treatment with either oral iron pills or IV iron infusions. Investigators will then check whether and how quickly the anemia improves, and survey participants on how satisfied they were with the treatment.

NCT ID: NCT04194047 Completed - Anemia Clinical Trials

Effects of Red Blood Cells Transfusion on Renal Blood Flow

Start date: March 1, 2020
Phase:
Study type: Observational

The renal Doppler resistive index (RRI) is a noninvasive tool that has been used to assess renal perfusion in the intensive care unit (ICU) setting. It is associated with the occurrence of acute kidney injury (AKI). Many parameters have been described as influential on the values of renal RI. Red blood cell (RBC) transfusion were shown to be able to increase renal oxygenation in animal model, whereas crystalloid resuscitation did not. We sought to describe the different effect of crystalloids infusion and RBC transfusion on renal blood flow, as evaluated with doppler ultrasound

NCT ID: NCT04191213 Recruiting - Clinical trials for Sickle Cell Anemia in Children

Gum Arabic as Anti-oxidant, Anti-inflammatory and Fetal Hemoglobin Inducing Agent in Sickle Cell Anemia Patients

GA&SCA
Start date: February 15, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

To study the efficacy of Gum Arabic as an anti-oxidant, anti-inflammatory and Fetal Hemoglobin-inducing agent among Sickle Cell Disease children. Half of participants will receive Gum Arabic and the other half will receive placebo